1) Synthesis and characterisation of 2-deoxy-2,2-difluoro-D-lyxo-hexopyranose (3)
To solution of 3,4,6-tri-O-acetyl-2-deoxy-2,2-difluoro-D-lyxo-hexopyranose (145 mg, 0.47 mmol, 1 equiv) in MeOH (2 mL), NaOMe (12.8 mg, 0.23 mmol, 0.5 equiv) was added.
The mixture was stirred at 0 °C for 105 min then at RT for 45 min. Amberlite IR-120 was added until neutral. The resin was filtred off and the filtrate was concentrated in vacuo.
The crude mixture was then purified by column cromatography (EtOAc) to give 68 mg of 3 (72%) as white solid. 
2) Synthesis and characterisation of 3-deoxy-3-fluoro-D-galactose (4)
This fluorosugar has been prepared via a slightly different route than reported. 
2.4) 3-Deoxy-3-fluoro-D-galactose (4).
To 700 mg (2.05 mmol) of 1,2:5,6−di−O−cyclohexylidene-3-deoxy-3-fluoro-α-Dgalactofuranose TFA/H 2 O (9:1, 10 mL) was added. The solution was stirred overnight at RT and evaporated. The crude mixture was then purified by column chromatography (DCM/MeOH, 80:20) to give 440 mg of s.m. and 120 mg of product (32%). To 440 mg (1.28 mmol) of recovered s.m. 5 mL of TFA/H 2 O (9:1) were added. The solution was stirred overnight and evaporated. The crude mixture was then purified by column chromatography (EtOAc/MeOH, 90:10) to give 140 mg (34% calculated on 700 mg of total starting material, 60% calculated on 440 mg of s.m. for this specific reaction). In both of the product, even after crystallisation from acetone, TFA was still present: Column chromatography with silica gel/K 2 CO 3 (90:10) as the solid phase and EtOAc as eluent was necessary to completely remove the TFA, and gave 120 mg of pure 4 (32%). Hz, H β -1), 4.55 (0.6H, ddd, J 48.1, 9.7, 3.6 Hz, H β -3), 4.25 (0.4H, ddd, J 7.4, 3.5, 0.9 Hz, H α -4), 4.19 (0.6H, ddd, J 6.2, 3.7, 0.6 Hz, H β -4), 4.10-4.01 (1.2H, m, H α -2 + H α -5), 3.81-3.66 (3.2H, m, H α -6 + H β -2 + H β -5 + H β -6) ppm. These data are similar to literature data. 
3) Protein expression and purification
The enzyme was expressed and purified as published. 6 Cultures of 800 mL LB media (containing 100 µg/mL ampicillin) were inoculated with 5 mL pre-culture (OD = 0.5-0.6) containing a single colony of WT GOase. The cells were harvested after overnight incubation at 26 ºC and lysed by sonication. The suspension was centrifuged and the pellet discarded. The supernatant was filtered and loaded onto a Ni-NTA column with a volume of 1mL resin pre-equilibrated in 0.5 mL NiSO 4 0.1M and 5 mL dH 2 O. The column was washed with 5mL of wash buffer (NaPi 20 mM, NaCl 500 mM, PMSF 1mM and 30 mM imidazole pH 7.4). The target protein was eluted and the fractions collected using an imidazole linear gradient (30 mM-1M). From SDS-PAGE analysis and subsequent
Coomassie staining more than 95% pure protein was acquired. The purified protein preparation was activated with Cu 2+ . A six times excess of CuSO 4 80 mM was added to the sample and incubated overnight at 4 ºC. The excess copper was removed the following morning using a filter column. The sample was diluted two times to 15 mL with NaPi 
4) Peroxidase assay
The relative activity, kinetics constants and conversion rates of the purified enzyme were measured using an ABTS-HRP coupled assay. was used to calculate enzyme activity.
5) Determination of V rel
The peroxidase assay described above (section 4) was used to determine the relative activities of WT GOase against each fluorinated sugar.
Substrate profile of WT GOase towards galactose and fluorinated analogues of Gal and Glc. The liquid phase assay was performed at substrate concentration of 50 mM and an enzyme concentration of 12.5 nM. Activity was determined by measuring the increase in absorbance at λ = 420 nm. Data points represent means and error is expressed as standard deviation (SD) from duplicate samples.
6) Determination of k cat and K M
For the kinetic characterisation of the protein, the peroxidase assay (section 4) was used and measurements were performed using a range of substrate concentrations (0.1 -1.0 M).
The kinetic constants k cat and K M were determined by fitting the data to the Michaelis- Michaelis-Menten curves representing the reaction rates at various substrate concentrations in the absence and presence of 2,3-dideoxy-2,2,3,3-tetrafluoro-D-galactose (5). The liquid phase assay was performed to determine whether 5 acts a competitive inhibitor. The concentration of 5 was kept constant at 7.5 mM whereas the concentration of Gal was increased from 7.5 mM to 45 mM. The concentration of WT enzyme used 2.5 nM. Activity was determined by measuring the increase in absorbance at λ = 420 nm. Data points represent means and error is expressed as standard deviation (SD) from triplicate samples 
